Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
435
9.020
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
73
3.820
 Why?
Immunologic Factors
13
2025
231
2.630
 Why?
Neurology
10
2018
106
2.340
 Why?
Immunosuppressive Agents
10
2024
684
1.730
 Why?
Neuromyelitis Optica
4
2023
129
1.170
 Why?
Natalizumab
11
2021
40
0.970
 Why?
Recurrence
8
2025
1004
0.930
 Why?
Diagnostic Errors
2
2017
161
0.740
 Why?
Brain
16
2025
2624
0.710
 Why?
Internship and Residency
5
2011
1045
0.710
 Why?
Drug Substitution
2
2019
51
0.670
 Why?
Fingolimod Hydrochloride
5
2020
36
0.650
 Why?
Rituximab
4
2020
162
0.620
 Why?
Data Collection
4
2011
649
0.610
 Why?
Dementia, Vascular
3
2009
18
0.600
 Why?
Drug Monitoring
1
2019
190
0.580
 Why?
Early Medical Intervention
1
2017
57
0.540
 Why?
Medication Adherence
2
2019
558
0.530
 Why?
Magnetic Resonance Imaging
24
2025
3387
0.530
 Why?
Early Diagnosis
2
2017
234
0.530
 Why?
Humans
87
2025
128499
0.520
 Why?
Glatiramer Acetate
6
2019
18
0.510
 Why?
Calcinosis
2
2009
230
0.500
 Why?
Physicians
4
2016
863
0.490
 Why?
Postural Balance
3
2018
198
0.470
 Why?
Antibodies, Monoclonal, Humanized
8
2023
758
0.460
 Why?
Fatigue
3
2018
316
0.400
 Why?
Dimethyl Fumarate
3
2020
11
0.380
 Why?
Immunoglobulin G
4
2023
844
0.370
 Why?
Middle Aged
39
2025
30923
0.360
 Why?
Practice Guidelines as Topic
1
2018
1490
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
26
0.340
 Why?
Adult
43
2025
35302
0.330
 Why?
Withholding Treatment
2
2021
70
0.330
 Why?
Psychiatry
2
2009
174
0.310
 Why?
Cysts
1
2009
108
0.290
 Why?
Demyelinating Diseases
4
2019
84
0.290
 Why?
HIV Long Terminal Repeat
3
2001
10
0.290
 Why?
Education, Medical
1
2011
244
0.290
 Why?
Certification
1
2008
94
0.290
 Why?
Female
49
2025
68268
0.280
 Why?
Autoantibodies
3
2023
1464
0.280
 Why?
Lymphopenia
2
2020
59
0.270
 Why?
Education
2
2007
100
0.270
 Why?
Male
40
2025
63045
0.270
 Why?
Central Nervous System Cysts
1
2006
13
0.270
 Why?
Clinical Trials as Topic
3
2016
1003
0.270
 Why?
Cerebral Arteries
1
2006
57
0.260
 Why?
Single-Blind Method
3
2023
268
0.260
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
49
0.260
 Why?
Cerebrovascular Disorders
1
2006
90
0.250
 Why?
Societies, Medical
4
2019
744
0.250
 Why?
DNA, Viral
2
1998
348
0.250
 Why?
Ethics, Medical
2
2015
78
0.240
 Why?
Treatment Outcome
12
2023
10162
0.240
 Why?
HIV Seropositivity
2
1998
119
0.240
 Why?
Databases, Factual
3
2016
1267
0.230
 Why?
Drug Industry
2
2016
106
0.220
 Why?
Double-Blind Method
4
2023
1856
0.220
 Why?
Conflict of Interest
2
2016
123
0.220
 Why?
AIDS Dementia Complex
3
2001
51
0.210
 Why?
Microglia
2
2024
229
0.210
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
59
0.200
 Why?
Heart Aneurysm
1
2002
10
0.200
 Why?
Quality of Health Care
2
2017
606
0.190
 Why?
B-Lymphocytes
5
2023
814
0.190
 Why?
Heart Septal Defects, Atrial
1
2002
53
0.190
 Why?
Lymphoma
2
2005
195
0.190
 Why?
Interferon beta-1a
2
2019
12
0.180
 Why?
Mental Disorders
2
2007
1007
0.180
 Why?
Neuroimaging
1
2023
279
0.180
 Why?
Education, Medical, Continuing
2
2015
121
0.180
 Why?
Central Nervous System Neoplasms
2
2005
149
0.180
 Why?
Brain Neoplasms
4
2016
1172
0.180
 Why?
Agammaglobulinemia
1
2020
33
0.170
 Why?
Interferon-gamma
1
2023
761
0.170
 Why?
Disease Progression
4
2021
2604
0.160
 Why?
Serum Sickness
1
2019
6
0.160
 Why?
Neutropenia
1
2020
134
0.160
 Why?
Indans
1
2019
11
0.160
 Why?
Oxadiazoles
1
2019
33
0.160
 Why?
Referral and Consultation
1
2005
728
0.160
 Why?
Diagnosis, Differential
4
2023
1412
0.160
 Why?
Adjuvants, Immunologic
3
2015
221
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.150
 Why?
Educational Measurement
3
2015
257
0.150
 Why?
Salvage Therapy
1
2019
134
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
252
0.140
 Why?
Herpesvirus 8, Human
1
1998
59
0.140
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
575
0.140
 Why?
Eye Movements
1
2018
59
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Young Adult
7
2024
12349
0.140
 Why?
Physician-Patient Relations
2
2016
530
0.140
 Why?
Patient Selection
2
2015
661
0.140
 Why?
Central Nervous System
2
2005
254
0.140
 Why?
Sarcoma, Kaposi
1
1998
76
0.140
 Why?
Herpesvirus 4, Human
1
2018
152
0.140
 Why?
Aged
9
2024
21976
0.130
 Why?
Nervous System Diseases
2
2024
252
0.130
 Why?
Herpesviridae Infections
1
1998
134
0.130
 Why?
Suicide, Assisted
1
1997
25
0.130
 Why?
Neurologists
1
2016
20
0.130
 Why?
Costs and Cost Analysis
1
2017
200
0.130
 Why?
Cost-Benefit Analysis
2
2016
569
0.130
 Why?
Estriol
1
2015
7
0.130
 Why?
Retrospective Studies
10
2024
14472
0.130
 Why?
Dizziness
2
2018
79
0.120
 Why?
Verbal Learning
2
2013
64
0.120
 Why?
Corpus Callosum
2
2006
66
0.120
 Why?
T-Lymphocytes
1
2023
1923
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
96
0.120
 Why?
Trust
1
2016
116
0.120
 Why?
Follow-Up Studies
6
2020
4874
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
50
0.110
 Why?
Exercise Therapy
1
2018
413
0.110
 Why?
Insurance, Health
1
2016
267
0.110
 Why?
Stroke
1
2002
1073
0.110
 Why?
Medication Reconciliation
1
2013
29
0.110
 Why?
CD40 Antigens
1
2014
88
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
136
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Anti-Inflammatory Agents
2
2006
470
0.100
 Why?
Population Surveillance
1
2016
435
0.100
 Why?
Sensation Disorders
1
2012
30
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Memory Disorders
1
2013
163
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
80
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
37
0.100
 Why?
HIV-1
2
2001
834
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
16
0.100
 Why?
Glioma
1
2016
354
0.100
 Why?
Optic Nerve
2
2005
64
0.090
 Why?
T-Lymphocyte Subsets
1
2014
409
0.090
 Why?
United States
8
2024
13840
0.090
 Why?
Gadolinium
4
2018
77
0.090
 Why?
Academies and Institutes
1
2011
49
0.090
 Why?
Self-Assessment
1
2011
68
0.090
 Why?
Learning
1
2015
399
0.090
 Why?
Nerve Regeneration
1
2010
62
0.090
 Why?
Fatal Outcome
3
2006
301
0.090
 Why?
Quality of Life
3
2021
2688
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Diagnostic Tests, Routine
1
2011
102
0.080
 Why?
Antigens, CD19
3
2007
115
0.080
 Why?
Biomarkers
3
2014
3893
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
19
0.080
 Why?
Severity of Illness Index
3
2014
2719
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
615
0.080
 Why?
Disease Management
1
2013
584
0.080
 Why?
Guidelines as Topic
1
2011
260
0.080
 Why?
Spinal Cord
3
2023
354
0.080
 Why?
Neuroprotective Agents
1
2009
109
0.070
 Why?
Physical Therapy Modalities
1
2011
292
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1262
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Workload
1
2009
151
0.070
 Why?
Immunoglobulin Variable Region
2
2004
79
0.070
 Why?
Antibodies, Monoclonal
2
2011
1357
0.070
 Why?
Neuropsychological Tests
2
2013
1005
0.070
 Why?
CD4-Positive T-Lymphocytes
1
1993
1045
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
14
0.070
 Why?
Headache Disorders
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
43
0.070
 Why?
Medical Records
1
2007
170
0.070
 Why?
Syndrome
2
2023
336
0.070
 Why?
Methylprednisolone
1
2006
82
0.070
 Why?
Huntington Disease
1
2007
49
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
92
0.060
 Why?
International Classification of Diseases
1
2007
122
0.060
 Why?
Contrast Media
3
2018
390
0.060
 Why?
Intracranial Hemorrhages
1
2006
80
0.060
 Why?
Antibody Formation
1
2007
290
0.060
 Why?
Adolescent
8
2024
20304
0.060
 Why?
Herpes Zoster
1
2010
317
0.060
 Why?
Canada
2
2019
346
0.060
 Why?
Aquaporin 4
1
2006
95
0.060
 Why?
DNA Mutational Analysis
1
2006
385
0.060
 Why?
Fellowships and Scholarships
1
2009
272
0.060
 Why?
RNA, Messenger
1
1992
2679
0.060
 Why?
Health Care Surveys
1
2007
558
0.060
 Why?
Patient Compliance
1
2009
560
0.060
 Why?
Surveys and Questionnaires
4
2016
5371
0.060
 Why?
Teaching
1
2007
210
0.060
 Why?
Cognition Disorders
1
2009
498
0.060
 Why?
Neurologic Examination
1
2005
115
0.060
 Why?
Analysis of Variance
3
2015
1273
0.060
 Why?
Colorado
2
2024
4399
0.060
 Why?
Program Evaluation
1
2009
872
0.060
 Why?
Erythrocytes
1
2010
673
0.060
 Why?
Affect
1
2007
284
0.060
 Why?
Central Nervous System Diseases
1
2005
67
0.060
 Why?
Neutrophils
1
2010
1192
0.060
 Why?
Simvastatin
1
2004
55
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.050
 Why?
Prevalence
2
2024
2553
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
38
0.050
 Why?
Faculty, Medical
1
2006
263
0.050
 Why?
B-Lymphocyte Subsets
1
2003
74
0.050
 Why?
Neurodegenerative Diseases
1
2024
112
0.050
 Why?
Cyclophosphamide
1
2003
228
0.050
 Why?
Radiography
1
2005
795
0.050
 Why?
Academic Medical Centers
1
2005
480
0.050
 Why?
Students, Medical
1
2006
315
0.050
 Why?
Anticoagulants
1
2006
634
0.050
 Why?
Single-Cell Analysis
1
2024
276
0.050
 Why?
Infusions, Intravenous
1
2023
394
0.050
 Why?
Patient Outcome Assessment
1
2023
125
0.050
 Why?
Membrane Glycoproteins
1
2004
468
0.050
 Why?
Induced Pluripotent Stem Cells
1
2024
222
0.050
 Why?
Lymphoma, B-Cell
2
2005
105
0.050
 Why?
Cross-Sectional Studies
1
2012
5045
0.050
 Why?
Dementia
1
2005
227
0.050
 Why?
Peptides
3
2013
915
0.050
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.050
 Why?
Time Factors
4
2018
6506
0.050
 Why?
Schools, Medical
1
2002
130
0.050
 Why?
Disability Evaluation
2
2014
285
0.050
 Why?
Clinical Competence
1
2008
1009
0.050
 Why?
Molecular Sequence Data
3
2004
2822
0.050
 Why?
Pain
1
2007
751
0.050
 Why?
Antibodies, Antinuclear
1
2001
66
0.040
 Why?
Atrophy
1
2021
170
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
145
0.040
 Why?
Consensus
1
2023
610
0.040
 Why?
Mobility Limitation
1
2020
58
0.040
 Why?
Venous Thrombosis
1
2002
176
0.040
 Why?
Child
5
2016
20805
0.040
 Why?
Interferon-beta
2
2011
88
0.040
 Why?
Lipids
1
2023
621
0.040
 Why?
Lymphocyte Activation
1
2003
1098
0.040
 Why?
Antibodies, Viral
1
2023
601
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
70
0.040
 Why?
Cerebral Infarction
1
1998
42
0.040
 Why?
Cell Separation
2
2014
312
0.040
 Why?
HIV Seronegativity
1
1998
25
0.040
 Why?
Transplantation, Autologous
1
2019
211
0.040
 Why?
Genes, myc
1
1998
50
0.040
 Why?
Base Sequence
2
2001
2137
0.040
 Why?
Astrocytoma
1
1998
121
0.040
 Why?
In Situ Hybridization
1
2018
291
0.030
 Why?
Gene Library
1
1997
116
0.030
 Why?
Risk Assessment
1
2006
3232
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
324
0.030
 Why?
Gene Rearrangement
1
1998
147
0.030
 Why?
Syndecan-1
2
2007
27
0.030
 Why?
Breast Neoplasms
1
2008
2135
0.030
 Why?
Morals
1
1997
71
0.030
 Why?
Managed Care Programs
1
1997
133
0.030
 Why?
Risk Factors
3
2008
9737
0.030
 Why?
Drug Administration Schedule
1
2018
764
0.030
 Why?
Viral Load
1
2018
449
0.030
 Why?
Flow Cytometry
2
2014
1142
0.030
 Why?
Mutation
1
2006
3696
0.030
 Why?
Polymerase Chain Reaction
1
1998
1027
0.030
 Why?
Survival Analysis
1
2018
1265
0.030
 Why?
Sequence Analysis, DNA
1
1997
775
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1276
0.030
 Why?
Child, Preschool
3
2016
10487
0.030
 Why?
Patient Care Team
1
2019
598
0.030
 Why?
Incidence
1
2020
2638
0.030
 Why?
Congresses as Topic
1
2015
211
0.030
 Why?
Propylene Glycols
1
2013
25
0.030
 Why?
Ocular Physiological Phenomena
1
1992
9
0.030
 Why?
HLA-DR Antigens
1
2014
224
0.030
 Why?
Sphingosine
1
2013
36
0.030
 Why?
beta-Galactosidase
1
1992
76
0.030
 Why?
Quality-Adjusted Life Years
1
2013
106
0.030
 Why?
Markov Chains
1
2013
116
0.030
 Why?
Drug Therapy, Combination
1
2015
1016
0.030
 Why?
Mice, Inbred DBA
1
1992
186
0.030
 Why?
Leukocyte Count
1
1993
326
0.020
 Why?
Haplotypes
1
2014
471
0.020
 Why?
Mental Recall
1
2013
190
0.020
 Why?
Organ Specificity
1
1992
290
0.020
 Why?
Comparative Effectiveness Research
1
2013
146
0.020
 Why?
Mice
2
2023
16620
0.020
 Why?
Reference Values
1
2013
780
0.020
 Why?
Animals
3
2023
34647
0.020
 Why?
CD3 Complex
1
2012
101
0.020
 Why?
Ki-67 Antigen
1
2012
107
0.020
 Why?
Thymus Gland
1
1992
309
0.020
 Why?
Intestine, Small
1
1992
145
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Hematologic Tests
1
2011
21
0.020
 Why?
Muscle Stretching Exercises
1
2011
18
0.020
 Why?
Depression
2
2011
1292
0.020
 Why?
Patient Participation
1
2015
409
0.020
 Why?
Clinical Laboratory Techniques
1
2011
93
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1358
0.020
 Why?
Recombinant Fusion Proteins
1
1992
636
0.020
 Why?
Amino Acid Sequence
2
2004
2044
0.020
 Why?
Physical Endurance
1
2011
262
0.020
 Why?
Aged, 80 and over
2
2016
7057
0.020
 Why?
Spinal Cord Neoplasms
1
1989
39
0.020
 Why?
Acyclovir
1
2010
99
0.020
 Why?
Cell Count
1
2010
310
0.020
 Why?
History, 19th Century
1
2009
57
0.020
 Why?
Respiratory Function Tests
1
2011
580
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
54
0.020
 Why?
Pilot Projects
2
2004
1568
0.020
 Why?
Injections
1
2009
173
0.020
 Why?
History, 21st Century
1
2009
180
0.020
 Why?
Autoimmunity
1
2014
860
0.020
 Why?
Electrocardiography
1
2011
608
0.020
 Why?
History, 20th Century
1
2009
288
0.020
 Why?
Gene Expression
1
1992
1455
0.020
 Why?
Mice, Transgenic
1
1992
2069
0.020
 Why?
Age of Onset
1
2009
495
0.020
 Why?
Health
1
2007
73
0.020
 Why?
Memory
1
2009
254
0.020
 Why?
Walking
1
2011
500
0.020
 Why?
Association Learning
1
2007
66
0.020
 Why?
Prognosis
2
2006
3780
0.020
 Why?
Cerebral Ventricles
1
2006
49
0.020
 Why?
Herpesvirus 3, Human
1
2010
331
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
842
0.020
 Why?
Motor Skills
1
2007
90
0.020
 Why?
Hypothalamus
1
2006
145
0.020
 Why?
Phenotype
1
2014
3051
0.020
 Why?
Genetics
1
2005
25
0.020
 Why?
Models, Theoretical
1
2009
542
0.020
 Why?
Immunologic Memory
1
2007
341
0.020
 Why?
Hospitalization
1
2015
2069
0.020
 Why?
Neurosciences
1
2005
29
0.010
 Why?
Social Support
1
2009
589
0.010
 Why?
Syndecans
1
2004
4
0.010
 Why?
Clinical Protocols
1
2006
254
0.010
 Why?
Internet
1
2009
613
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
253
0.010
 Why?
Anisotropy
1
2004
71
0.010
 Why?
Immune System
1
2005
176
0.010
 Why?
Antiviral Agents
1
2010
711
0.010
 Why?
Plasma Cells
1
2004
67
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
13
0.010
 Why?
Videotape Recording
1
2003
34
0.010
 Why?
Infrared Rays
1
2003
21
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
112
0.010
 Why?
Saccades
1
2003
39
0.010
 Why?
Antilymphocyte Serum
1
2003
63
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Astrocytes
1
2005
189
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
256
0.010
 Why?
Whole-Body Irradiation
1
2003
76
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
126
0.010
 Why?
Feasibility Studies
1
2006
863
0.010
 Why?
Observer Variation
1
2003
313
0.010
 Why?
Immunoglobulins
1
2003
158
0.010
 Why?
Mice, Inbred C57BL
1
1992
5281
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2517
0.010
 Why?
Administration, Oral
1
2004
767
0.010
 Why?
Sex Characteristics
1
2007
722
0.010
 Why?
Longitudinal Studies
1
2009
2710
0.010
 Why?
Age Factors
1
2009
3122
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
5
0.010
 Why?
Urinary Tract Infections
1
2003
147
0.010
 Why?
Consensus Sequence
1
2001
72
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
941
0.010
 Why?
Cytomegalovirus Infections
1
2003
186
0.010
 Why?
Biopsy
1
2005
1079
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
20
0.010
 Why?
Infant
1
2015
9001
0.010
 Why?
Cohort Studies
1
2011
5402
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
84
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
59
0.010
 Why?
Predictive Value of Tests
1
2006
1938
0.010
 Why?
Acute Disease
1
2003
965
0.010
 Why?
Research
1
2003
409
0.010
 Why?
Combined Modality Therapy
1
2003
1201
0.010
 Why?
Lung
1
1992
3748
0.010
 Why?
Arachnoid
1
1998
11
0.010
 Why?
Sensitivity and Specificity
1
2003
1817
0.010
 Why?
Survival Rate
1
2003
1871
0.010
 Why?
Virus Replication
1
2001
444
0.010
 Why?
Monocytes
1
2001
546
0.010
 Why?
Models, Biological
1
2005
1698
0.010
 Why?
Binding Sites
1
2001
1244
0.010
 Why?
Case-Control Studies
1
2004
3339
0.010
 Why?
Aging
1
2007
1755
0.010
 Why?
Reproducibility of Results
1
2003
3021
0.010
 Why?
Transcription, Genetic
1
2001
1404
0.010
 Why?
DNA-Binding Proteins
1
2001
1423
0.010
 Why?
Cells, Cultured
1
2001
4017
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)